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Abstract: The protease α-chymotrypsin (α-CT) was covalently immobilized on a low-density
polyethylene (LDPE) surface, providing a new non-leaching material (LDPE-α-CT) able to preserve
surfaces from biofilm growth over a long working timescale. The immobilized enzyme showed a
transesterification activity of 1.24 nmol/h, confirming that the immobilization protocol did not
negatively affect α-CT activity. Plate count viability assays, as well as confocal laser scanner
microscopy (CLSM) analysis, showed that LDPE-α-CT significantly impacts Escherichia coli biofilm
formation by (i) reducing the number of adhered cells (−70.7 ± 5.0%); (ii) significantly affecting
biofilm thickness (−81.8 ± 16.7%), roughness (−13.8 ± 2.8%), substratum coverage (−63.1 ± 1.8%),
and surface to bio-volume ratio (+7.1 ± 0.2-fold); and (iii) decreasing the matrix polysaccharide
bio-volume (80.2 ± 23.2%). Additionally, CLSM images showed a destabilized biofilm with many
cells dispersing from it. Notably, biofilm stained for live and dead cells confirmed that the reduction
in the biomass was achieved by a mechanism that did not affect bacterial viability, reducing the
chances for the evolution of resistant strains.
Keywords: biofilm; anti-biofilm surface; surface functionalization; α-chymotrypsin; proteinase
1. Introduction
The main strategy for limiting bacterial loading in medical and industrial settings relies on
regular cleaning and disinfection treatments aimed at killing the microbial cells on solid surfaces [1].
The incorporation of disinfectants, antiseptics, antibiotics, and metallic nanoparticles into several
materials has also been proposed as a strategy to minimize pathogen growth on surfaces [2–5].
However, these strategies have shown limited efficacy and recurrent drawbacks, making their use
questionable [2,6].
The major concern lies in the property of bacteria to coexist in a protective self-produced
extracellular matrix within an extremely coordinated and structured surface-adhered community,
known as biofilm [7]. It has been established that antibiotic overuse also triggers increased multidrug
resistance in many microbial taxa [8,9]. Biofilms display high tolerance to antimicrobial agents as a
result of the matrix itself, which acts as a protective barrier, and because of the reduced metabolic
rate of bacteria and the presence of some dormant cells highly tolerant to a variety of drugs [10].
Additionally, most antimicrobial-releasing materials have shown a discontinuous release rate and
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short-term efficiency, typically no longer than 24 h, which make them less suitable for long-term
applications [11,12].
In the last decade, researchers have concentrated their attention on approaches involving
mechanisms of action that do not affect microbial life, including those that sabotage the biofilm
lifestyle in a non-toxic way, and with modalities that decrease the selection pressure for drug-resistant
mutations [13]. A straightforward approach is to target the biofilm matrix. Indeed, the deployment of
enzymes that degrade the polymers that make up the biofilm matrix have been proposed as an effective
approach to impact biofilm architecture while still preserving cell integrity [14]. Since a biofilm matrix
encases bacterial cells within the biofilm colony, matrix degradation results in the destabilization of
the biofilm organization and its physical integrity [15]. Therefore, the biofilm multicellular structure is
compromised with a modality that does not affect cellular functions crucial for microbial survival [14].
For example, glycosidases as well as proteases or deoxyribonuclease have been reported to degrade
bacterial matrix [16–19].
Despite these promising results, the real application of these molecules has been less feasible due
to the lack of a suitable technology for efficiently retaining the anti-biofilm enzyme over a working
timescale. Indeed, until now, attention has been mainly focused on the activity of enzymes in solution
or as coatings. In addition, most of the effects studied occur during the initial surface attachment
phase, which only partially involves matrix production by cells [13].
In the present work, the protease α-chymotrypsin (α-CT) was covalently immobilized on a
low-density polyethylene (LDPE) surface to provide a new non-leaching material able to preserve
surfaces from biofilm growth over a long working timescale. Immobilization makes enzymes
more robust and more resistant to environmental changes in comparison to the counterpart free
in solution [20]. More importantly, the heterogeneity of the immobilized enzyme systems allows
continuous operation of enzymatic processes and rapid reactions [20]. As this strategy does not act
by killing cells, it does not impose a selective pressure that would cause the onset of resistance [21].
Additionally, as the multicellularity of the biofilm is compromised, the planktonic state might be
forced, restoring the efficacy of antimicrobial agents [22]. Notably, in this paper the anti-biofilm
activity of immobilized enzymes was tested using a high-level and realistic approach by setting up
an Escherichia coli laboratory-scale model system able to simulate the real conditions encountered
in vivo, and provides information about the new material effect on the structure of a well-established
mature biofilm [23].
2. Results
2.1. Immobilized α-CT Retains Its Activity
The possibility to link enzymes to plastics (e.g., polypropylene and polyethylene) was previously
shown by our team [24]. The procedure indicates that the preventive plasma treatment of the surface
is crucial for providing the plastic surface with functional groups exploitable for the covalent binding
of the enzyme to the surface by glutaraldehyde (GA). Herein, on the basis of these previously reported
results obtained with different proteases, α-CT immobilization was carried out by submitting LDPE
coupons to a plasma treatment for 30 min and using GA as a linker. After washing (no leaching
was observed on placing the coupons in water before their use) and drying, LDPE-α-CT showed
transesterification activity in toluene of 1.24 nmol/h. Enzyme activity was measured in organic solvent
as, in the immobilized form, the enzyme catalyzes the reaction in an insoluble form (heterogeneous
solid/liquid catalysis), i.e., in the presence of mass transfer limitation conditions [25]. In this physical
condition, the enzyme activity tested in organic solvent gave more reproducible results with respect to
the methods carried out in aqueous media.
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2.2. LDPE-α-CT Reduces Biofilm Biomass
Experiments showed that LDPE-α-CT had an optimal anti-biofilm performance, reducing
viable adhered cells by 70.7 ± 5.0% in comparison to the LDPE control surface (Figure 1).
Significant differences were also detected among the negative control samples, namely LDPE and
LDPE-GA (Figure 1). Indeed, the number of adhered cells on LDPE-GA was 31.0 ± 5.8% lower than
those attached on LDPE.
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2.3. LDPE-α-CT Reduces Biofilm Biomass without Affecting Cell Viability
Epifluorescence microscopic techniques were additionally used to provide image analysis and
in situ quantification of bacterial cells. Figure 2 shows direct microscope visualizations of the total
biofilm biomass on functionalized and non-functionalized coupons, stained for live and dead cells.
Microscope assay revealed that the biofilm displayed a number of dead cells lower than 1.9 ± 1.1%,
with no significant differences in the percentage of stained area between the LDPE and LDPE-GA
surfaces, whereas a lower number of dead cells were found on LDPE-α-CT (Figure 2) (dead cells:
LDPE: 1.9 ± 1.1%; LDPE-GA: 1.3 ± 1.1%; LDPE-α-CT: 0.7 ± 0.5%).
Biofilm on LDPE-α-CT showed a decreased number of live cells compared to the LDPE control
surface, by up to 66.4 ± 11.0%, confirming results obtained in the plate count viability assay (Figure 2)
(live cells: LDPE: 73.0 ± 14.1%; LDPE-α-CT: 24.5 ± 6.6%). A reduction of 23.9 ± 2.9% in the percentage
of live cells on LDPE-GA compared to LDPE cells was also detected (live cells: LDPE-GA: 56.2 ± 7.0%)
(Figure 2).
Statistical analysis of relative viability revealed no significant difference between LDPE, LDPE-GA,
and LDPE-α-CT materials (relative viability: LDPE: 39.3 ± 15.5; LDPE-GA: 42.6 ± 7.5; LDPE-α-CT:
36.3 ± 4.8).
Coupons without biofilm and stained with the same dye did not produce detectable fluorescence,
therefore no false positive signals were produced (Figure 2E).
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(LDPE-α-CT). Data represent the mean ± standard deviation of four independent measurements. 
Letters a, b and c indicate significant differences (Tukey’s HSD, p ≤ 0.05) between the means of 
different surfaces. (B–D) Representative epifluorescence microscope images of E. coli biofilm stained 
with a Live/Dead BacLight viability kit and grown on LDPE (B), LDPE-GA (C), and LDPE-α-CT (D) 
surfaces (60×, 1.0 NA water immersion objective). Green fluorescence corresponds to E. coli live cells 
(λex: 480 nm and λem: 516 nm) and red fluorescence corresponds to E. coli dead cells (λex: 581 nm and 
λem: 644 nm). (E) Representative epifluorescence microscope image of LDPE, LDPE-GA, and LDPE-
α-CT without biofilm and stained with a Live/Dead BacLight viability kit showing no detectable 
fluorescence. Scale bar = 20 µm.  
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Figure 2. Epifluorescence microscope analysis. (A) Percentage of live and dead cells within the
biofilm grown on non-functionalized (LDPE and LDPE-GA) and functionalized polyethylene surfaces
(LDPE-α-CT). Data represent the mean ± standard deviation of four independent measurements.
Letters a, b and c indicate significant differences (Tukey’s HSD, p≤ 0.05) between the means of different
surfaces. (B–D) Representative epifluorescence microscope images of E. coli biofilm stained with a
Live/Dead BacLight viability kit and grown on LDPE (B), LDPE-GA (C), and LDPE-α-CT (D) surfaces
(60×, 1.0 NA water immersion objective). Green fluorescence corresponds to E. coli live cells (λex:
480 nm and λem: 516 nm) and red fluorescence corresponds to E. coli dead cells (λex: 581 nm and λem:
644 nm). (E) Representative epifluorescence microscope image of LDPE, LDPE-GA, and LDPE-α-CT
without biofilm and stained with a Live/Dead BacLight viability kit showing no detectable fluorescence.
Scale bar = 20 µm.
2.4. LDPE-α-CT Affect Biofilm Morphology
Biofilm morphology was assessed by confocal laser scanner microscopy (CSLM) after staining with
SYBR Green I and Texas Red-labeled concanavalin A. Projection analys s as well as three-dim n ionally
(3D) reconstructed CLSM images showed a complex biofilm on the LDPE biofilm with an intense d
and green signal corresponding to multi-layer of cells (green signal) organized in macro-colonies
inside a well-structured polysaccha ide matrix (red signa ) (Figure 3A–C). Interestingly, cells were
mostly l cated at the bottom of the biofilm, in contact with the surface, whereas the matrix was
gen ally found over the cellular componen . On the contrary, biofilm growth LDPE-α-CT resulted
in a significant decrease of thickness with a mono-layer of dispersed c lls and very l w p esence of
polysaccharide matrix (Fig re 2B–D). In addition, there were many cells dispersing from the biofilm.
No et ctable fluor sc nce was observe when coupons without biofilm were stained with the
same yes, indicating at false positive signals were not produced (Figure 3E).
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Figure 3. Confocal laser scanning microscopy analysis. Representative projection analysis (A,B)
and three-dimensionally (3D) reconstructed CLSM images (C,D) of E. coli biofilm grown on
non-functionalized LDPE surface (A,C) and LDPE-α-CT (B,D) functionalized surface (63×, 0.9 NA
water immersion objective). The arrows indicate cells detaching from the biofilm. Live cells were stained
green ith S B reen I (λex at 488 n , λem at 520 nm), whereas the polysaccharide matrix as stained
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t ickness belo 4 , it 16.7 ith respect to t e iofil r
E. Additionally, biofilm roughness wa slightly decreased in both LDPE-GA (−13.8 ± 1.7%)
and LDPE-α-CT (−13.8 ± 2.8%), indicating a more uniform biofilm layer i comparison to the
control LDPE biofilm. On LDPE-α-CT, the substratum covered by biofilm was significantly lower
(−63.1 ± 1.8%) than that in the corresponding non-functionalized LDPE. Interestingly, a small
reduction in the substratum coverage was also reco ded for the biofilm grown on LDPE-GA
(−13.8 ± 1.7%). Total bio-volume of the biofilm grow on LDPE-α-CT was found to be significan ly
decreased compared to both LDPE and LDPE-GA b films, with a reduction of up to the 78.0± 16.1% in
comparison to the LDPE control surface. Indeed, LDPE-α-CT exhibited a reduced cellular bio-volume
by 71.7 ± 3.4% and a reduced polysaccharide atrix bio-volume by 80.2 ± 23.2% compared to the
LDPE surface. Additionally, a statistically significant reduction in the cellular bio-volume was f und
in the biofilm grown on LDPE-GA compared to that grown on LDPE (−21.8 ± 1.0%). The matrix/cell
bio-volume ratio always displayed a value over 1.9 wi h no statistically significant differences among
surfaces, which indicates a predominance of matrix with respect to th ce lular component. The biofil
ex osed s rface/bio-volume ratio significantly increased when biofilm as gro n - -
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(7.1 ± 0.2-fold) whereas no significant differences were detected between biofilms grown on LDPE
and LDPE-GA.
Table 1. Biofilm morphological parameters of biofilm grown on non-functionalized (LDPE, LDPE-GA)
and functionalized polyethylene surfaces (LDPE-α-CT). In the brackets, percentage reduction/increase
in comparison to the LDPE control sample is reported when significant. Data represent the mean ±
standard deviation of four independent measurements.
Parameter LDPE LDPE-GA LDPE-α-CT
Thickness (µm) 20.5 ± 5.0 a 19.1 ± 4.9 a 3.7 ± 1.1
b
(−81.8 ± 16.7)
Roughness 0.25 ± 0.03 a 0.22 ± 0.02
b
(−11.1 ± 1.0)
0.21 ± 0.04 b
(−13.8 ± 2.8)
Substratum coverage (%) 72.3 ± 3.8 a 62.3 ± 1.2
b
(−13.8 ± 1.7)
26.7 ± 1.3 c
(−63.1 ± 1.8)
Total bio-volume
(µm3 µm−2) 89.4 ± 20.1
a 76.3 ± 21.2 a 19.7 ± 4.1
b
(−78.0 ± 16.1)
Cells bio-volume
(µm3 µm−2) 23.7 ± 4.0
a 18.5 ± 0.9 b
(−21.8 ± 1.0)
6.7 ± 0.3 c
(−71.7 ± 3.4)
Polysaccharide matrix
bio-volume (µm3 µm−2) 65.8 ± 7.8
a 57.8 ± 14.9 a 13.0 ± 3.8
b
(−80.2 ± 23.2)
Matrix/cells
bio-volume ratio 2.8 ± 0.6
a 3.1 ± 0.8 a 1.9 ± 0.5 a
Surface/bio-volume
(µm2 µm−3) × 10−2 1.1 ± 0.3
a 1.3 ± 0.4 a 8.7 ± 1.7
b
(+7.8 ± 1.6-fold)
Superscript letters a, b and c indicate significant differences (Tukey’s HSD, p ≤ 0.05) between the means of
different surfaces.
3. Discussion
In this study, the protease α-CT was covalently and irreversibly immobilized on an LDPE
surface to provide a new material with anti-biofilm properties. LDPE was chosen as it is a polymer
with excellent chemical resistance, low wetting properties in aqueous media, high impact strength,
light weight, and high flexibility [26,27] and is currently used for many applications, e.g., biomedical
devices [28] and food packaging [29].
Among others (e.g., subtilisin Carlsberg from Bacillus licheniformis, lipase from Burkholderia cepacia
or pectinase from Aspergillus niger), α-CT was preferred as, in a previous work by these authors,
this enzyme showed the highest transesterification activity once immobilized with GA [24,30]. Notably,
the same authors observed an increase in the catalytic activity of α-CT after treatment with GA [31].
In addition, several studies confirmed the ability of α-CT to limit biofilm formation on solid surfaces,
both free-in-solution treatment as well as in coatings [32–37].
Beside the previously promising results, the use of the free enzyme has drawbacks resulting
from sensitivity to process conditions, low stability, or propensity to be inhibited by other molecules.
Indeed, applications are limited by the lack of long-term operational stability and the technical
challenge of enzyme recovery and reuse [38]. Additionally, enzyme coatings suffer decreased activity
as degradation of the coating quickly occurs [39].
Compared to the enzyme used free in solution as well as in coatings, chemical immobilization
ensures the retention of the catalytic activity, which allows the enzyme to be used repeatedly and
continuously, as well as confining the protease activity where biofilm formation occurs [30,38].
Indeed, the nature of the covalent binding guarantees the long life of the material since molecules
are permanently attached and integrated into the polymer scaffold structure [40], preserving the
surrounding environment from enzyme contamination. This is especially useful in those fields where
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chemical contamination in the final product must be avoided for safety reasons, e.g., in food contact
processing surfaces [41]. In addition, immobilization enhances the enzyme stability under both
storage and operational conditions, e.g., by increasing its thermal stability, and therefore making
it more attractive for diverse applications, especially when surfaces are subjected to harsh reaction
conditions [24,31,42]. Recently, Spadoni-Andreani et al. [37] covalently linked α-CT on polypropylene,
thus providing a new material able to preserve the surface from Candida albicans colonization.
The authors carried out covalent enzyme immobilization by activating the surface with a plasma
treatment and linking the enzyme with GA. Herein, a similar protocol was applied, and α-CT was
immobilized on LDPE coupons after a plasma treatment of 30 min and using GA as a linker.
Plasma technology was previously employed to improve LDPE surface properties, leading to the
generation of activated species including hydrophilic functional groups on the first molecular layers
of the material [40]. Functional groups allowed the initiation of the surface enzyme immobilization
using GA as a linker. Among various cross-linking agents, GA has been long used for protein
immobilization, including a number of enzymes [43–45]. Indeed, GA has been successfully used to
covalently immobilize α-CT onto modified polyvinyl chloride microspheres [46] as well as on silica
beads [47]. Here, for the first time, the peculiar properties of plasma technology and GA were combined,
giving the right condition for α-CT immobilization on the LDPE surface. Indeed, the plasma treatment
was crucial for providing the plastic surface with functional groups exploitable for the covalent
binding of the enzyme to the surface, whereas the inclusion of the spacer GA was essential to improve
conformational flexibility, to restrict interaction among immobilized enzyme molecules, and to enhance
enzymatic activity [37]. Previous literature also highlighted the role of GA in retaining much of the
original activity of enzyme when used as linker in the immobilization process, allowing the new
material to be reused more than six times without loss of efficacy [46]. The combination of plasma
treatment with a linker seems also to be instrumental to retain the anti-biofilm activity over a long
timescale. Indeed, in the past, the coupling of plasma treatment with the linker 2-hydroxyethyl
methacrylate was used to functionalize LDPE surfaces with small molecules, providing new materials
able to maintain their anti-biofilm performance after having been used for more than 10 times [40].
In a previous work by these authors, it was shown that α-CT activity was negligibly affected
by the immobilization reaction with GA. Furthermore, it was shown that GA has an activating effect
on α-CT [31]. In line with the previous work, α-CT immobilized on LDPE showed protease activity,
confirming that immobilization did not affect the enzyme activity. This promising result opens up
the possibility to extend the adopted immobilization protocol to other polymeric materials. Notably,
the use of plasma technology coupled with GA makes all surfaces, including those that do not possess
the required chemical features, suitable for covalent binding [45,48]. Plasma sources can be also
used to modify three-dimensional structures and is therefore not limited to thin, flat samples [49].
Moreover, GA is not corrosive to various substrata, including stainless steel, soft metals, rubber,
and glass [50]. In this paper, the ability of the new material to affect cell adhesion and biofilm structure
was evaluated against E. coli, using a Center for Disease Control (CDC) biofilm reactor able to simulate
the conditions to which surfaces of a wide range of applications are subjected during their use,
according to previous literature [51,52]. Moreover, with the aim of transferring the technology to
consumer products suitable for widespread application, standard procedures were used to evaluate
the efficacy of the anti-biofilm material.
Experiments showed that the biofilm was significantly affected when grown on LDPE-α-CT.
Plate count viability assays as well as CLSM analysis displayed a significant reduction in both the
amount of adhered cells (over 70%) and matrix production (up to 80.2%). Biofilm stained for live
and dead cells confirmed that the reduction in biomass was achieved by a mechanism that did not
affect bacterial viability, reducing the chances for the evolution of resistant strains [22]. Morphology
analysis displayed a statistically significant decrease of biofilm thickness on LDPE-α-CT (up to 81.8%),
whereas the biofilm exposed surface/bio-volume ratio was found to be significantly increased (up
to 7.1-fold). A high surface to bio-volume ratio usually corresponds to the presence of single cells
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and small cell clusters attached to the substratum [53]. Moreover, it is an indicative parameter of
biofilm adaptation to the environment and it has been shown to increase in stress conditions [54].
Indeed, an increase in the specific surface area of the biofilm could optimize nutrient capture from the
environment, especially when the role of the matrix to retain nutrient particles fails [55].
E. coli autotransporter adhesins, e.g., the outer membrane protein Antigen 43, were found to
be instrumental in promoting cell-to-cell adhesion and aggregation at the initial stages of biofilm
formation [56–58]. Moreover, E. coli proteinaceous amyloid curli fibers play important roles in
the irreversible adhesion, enhance initial cell-cell interactions, and ensure the integrity of the
three-dimensional biofilm architecture [59–65]. Notably, the inhibition of curli assembly has been
found to result in a decrease of E. coli biofilm formation, with no apparent bactericidal or bacteriostatic
effects [66]. Extracellular proteins also regulate biofilm detachment and dispersal through the
enzymatic degradation of polysaccharides, proteins, and nucleic acids [67,68]. Serine proteases,
including α-CT, have been reported to be effective in biofilm eradication via hydrolysis of both the
proteinaceous component of the matrix and the proteins (e.g., adhesins) involved in cell adhesion
to the surface [14,69,70]. Therefore, as proteins are essential for biofilm formation, their inactivation
through the cleavage of their peptide bonds inevitably results in a weakened biofilm.
According to previous literature, in this study, 3D reconstructed CLSM images showed a seriously
destabilized biofilm with many cells being dispersed from the substrate. Since the extracellular matrix
holds the individual cells together, the enzymatic degradation of the matrix proteins inevitably causes
a massive cellular dispersal event [14,22]. Once cells have returned to the planktonic lifestyle, they are
more susceptible to both immune systems and the conventional antimicrobials as compared to those
in intact biofilm [71]. Additionally, the increased values of the surface to bio-volume ratio leave
more biofilm surface available for antibiotic action [72]. Therefore, the combination of a LDPE-α-CT
surface with conventional antimicrobial treatments might be a step toward maximizing the anti-biofilm
performance of this new material, making cleaning treatments and disinfection procedures effective at
low doses. This allows a more potent control against the development of drug-resistant strains [73].
The effect of the introduction of a GA linker into the LDPE polymer backbone on biofilm
formation was also evaluated. Indeed, the experiments showed that the linked GA alone
contributed, though slightly, to decrease the biofilm formation on the surface (up to 31.0%)
(Figure 2A,C), with a mechanism that did not affect cell viability. A weak GA effect on Bacillus cereus,
Pseudomonas fluorescens, Staphylococcus aureus, and E. coli biofilm formation was previously reported in
the literature [74–77]. However, these studies highlighted that GA had a significant effect on biofilm
removal, inducing sloughing events, only under long-term exposure [75]. The anti-biofilm effect of
GA could be attributed to its two aldehyde groups which can interact with microbial cell constituents,
among these the amino groups of the proteins within the biofilm. Indeed, GA forms methylene bridges,
which may play a part in subsequent reactions including cross-linking with another protein chain in
the cells. This leads to the removal of water from the biofilm followed by a dehydration effect [77,78].
In addition, it is reported that GA causes the deformation of alpha-helix structures in proteins on
the outer cellular layers [79], which may include some proteins important for bacterial adhesion and
biofilm formation. Indeed, studies have shown the strong binding of GA to the outer membrane
proteins of E. coli [80], and its role in E. coli biofilm formation is well known [81]. Other researchers
have suggested that GA also reacts with proteins of the polymeric matrix, leading to the disruption of
the matrix structure [74]. Notably, GA is reported to enhance enzyme activity in the immobilization
process as it introduces intermolecular cross-linking in proteins or it improves the attachment of
enzyme molecules to the support [31,82].
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4. Materials and Methods
4.1. Polymeric Surface Preparation
LDPE coupons (Ø 1.3 cm) were functionalized with α-CT according to
Spadoni-Andreani et al. [31]. Briefly, LDPE coupons were preventively washed with bi-deionized
water and acetone and then dried. Next, they were activated by exposure to O2 plasma for 30 min
using a Harrick Plasma PDC-002 plasma cleaner (740 V, 40 mA, 29.6 W, Ithaca, NY, USA). This step
is crucial for the chemical functionalization of the coupon surface (e.g., the formation of carboxyl
and hydroxyl groups) [24]. Just after the plasma treatment, enzyme immobilization was carried out,
loading onto the coupon 80 µL of α-CT solution (5 mg/mL) in buffer A (0.02 M potassium phosphate,
pH 7.2), containing 0.005% (v/v) glutaraldehyde (GA). Then the solution was left to evaporate
overnight at 25 ◦C and under vacuum. Control coupons were analogously prepared without α-CT.
4.2. Evaluation of Immobilized α-CT Activity
Activity of the immobilized α-CT was tested in toluene (0.5 mL) measuring the alcoholysis rate of
N-acetyl phenylalanine ethyl ester (1 mg/mL) in the presence of 1-propanol (5%). Tests were carried out
using 3-mL vials shaken at 150 rpm at 25 ◦C. At a scheduled time, product formation was analyzed by
a GC-FID Agilent 6850 (Santa Clara, CA, USA) networked GC system and with a polydimethylsiloxane
column (30 m, 0.32 mm, film thickness 0.25 µm) (Agilent Technologies 19091Z-413E) with H2 as carrier
gas and N2 and air as support gases, split 80, constant flow 2.7 mL/min, injector and FID heated at
250 ◦C, with a temperature ramp of 10 ◦C/min from 160 ◦C, held for 0.5 min, further heated to 240 ◦C,
and held for 1 min.
4.3. E. coli Strain and Growth Condition
E. coli strain MG1655 was used as a model system for bacterial biofilms, being a cosmopolitan
bacterium that shares a core set of genes with clinically relevant serotypes and foodborne pathogen
strains, including genes involved in biofilm formation [83]. The strain was stored at −80 ◦C in
suspensions containing 20% glycerol and 2% peptone, and was routinely grown in Luria–Bertani broth
(LB, Sigma-Aldrich, St. Louis, MO, USA) at 37 ◦C.
4.4. Biofilm Growth in the CDC Reactor
E. coli biofilm was grown on non-functionalized (LDPE and LDPE-GA) and functionalized
(LDPE-α-CT) coupons in the CDC biofilm reactor (Biosurface Technologies, Bozeman, MT, USA)
according to Cattò et al. [84]. Briefly, the bioreactor was inoculated with 400 mL of sterile LB medium
with the addition of 1 mL of diluted pre-washed overnight culture containing 107 cells of E. coli.
The culture was grown at 37 ◦C with continuous stirring for 24 h. When the 24-h adhesion phase was
over, the peristaltic pump was started and sterile 10% LB medium was continuously pumped into the
reactor at a rate of 8.3 mL/min. After 48 h of dynamic phase, functionalized and non-functionalized
coupons were removed, gently washed with phosphate-buffered saline (PBS, 0.01 M phosphate buffer,
0.0027 M potassium chloride, pH 7.4) and processed for analysis.
4.5. Plate Count Viability Assay
Collected coupons were transferred to 5 mL of PBS, and sessile cells were removed from the
coupon surface by 30 s vortex mixing and 2 min sonication (Branson 3510, Branson Ultrasonic
Corporation, Dunburry, CT, USA) followed by another 30 s vortex mixing. Serial dilutions of the
resulting cell suspensions were plated on Tryptic Soy Agar (TSA, Fisher Scientific, Pittsburgh, PA,
USA) and incubated overnight at 37 ◦C. Colony forming units (CFUs) were determined by the
standard colony counting method. Obtained data were reported as the number of viable bacterial
cells normalized to the area and means were calculated. The efficacy of the anti-biofilm material was
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calculated as the percentage reduction of the CFUs with respect to the LDPE control. Four coupons for
each surface were analyzed. The experiment was repeated four times for a total of 16 coupons analyzed.
4.6. Epifluorescence Microscopy Analysis
The percentage of live and dead cells in the biofilm biomass grown on both non-functionalized
and functionalized coupons was determined using a Live/Dead BacLight viability kit (L7012,
Molecular Probes-Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA). Biofilm was
incubated with 2 µL of each fluorescent probe per ml of sterile filtered PBS at room temperature in
the dark for 25 min and then rinsed with sterile PBS, according to the manufacturer’s instruction.
Coupons without biofilm were also stained with the dyes in order to exclude any false positive
signals. Biofilm samples were visualized using a Nikon Eclipse E800 epifluorescent microscope with
excitation at 480 nm and emission at 516 nm for the green channel and excitation at 581 nm and
emission at 644 nm for the red channel (Tokyo, Japan). Images were captured with a 60×, 1.0 NA
water immersion objective and analyzed via MetaMorph 7.5 software (Molecular Devices, Sunnyvale,
CA, USA). The percent area of stained cells was obtained by calculating at least 10 random images for
each sample. The efficacy of the anti-biofilm material was calculated as the percentage reduction in the
stained cell area with respect to the LDPE control images. Relative viability within the biofilm was
determined by dividing the percent area of the live cells by the percent area of the dead cells in each
sample. Four coupons of each surface were analyzed. The experiment was repeated four times for a
total of 16 coupons analyzed.
4.7. Confocal Laser Scanning Microscopy (CLSM) Analysis
Three-dimensional morphology of biofilm growth on non-functionalized and functionalized
surfaces was analyzed by CLSM according to Cattò et al. [85]. Biofilm was stained with
200 µg/mL lectin concanavalin A-Texas Red conjugate dye (C825, Molecular Probes-Life Technologies,
Thermo Fisher Scientific) to visualize the polysaccharide component of the extracellular polymeric
substances (EPS) and 1:1000 SYBR Green I fluorescent nucleic acid dye (S7563, Molecular Probes-Life
Technologies, Thermo Fisher Scientific) to display biofilm cells, in the dark for 30 min. Coupons without
biofilm were also stained in order to exclude any false positive signals. Biofilm samples were visualized
using a Leica SP5 CLSM with excitation at 488 nm and emission at 520 nm for the green channel
and excitation at 543 nm and emission at 615 nm for the red channel. Images were captured with a
63×, 0.9 NA water immersion objective and projections and 3D reconstructed images of biofilm were
generated using the Imaris software package (Bitplane Scientific Software, Zurich, Switzerland).
Quantitative biofilm structural parameters were calculated, including (i) mean thickness,
which identifies the mean distance from the substratum in the direction normal to the substrate
where there is biofilm; (ii) roughness, a quantity calculated from the thickness distribution and that
describes the heterogeneity of the biofilm; (iii) substratum coverage, the percentage of substrate area
occupied by the biofilm; (iv) surface-to-volume ratio, which reflects the fraction of biofilm area that is
exposed to nutrients; and (v) bio-volume, of both cells and the polysaccharide matrix, which provides
an estimation of the biomass in the biofilm [86]. Biofilm morphological parameters were obtained via
MetaMorph 7.5 (Molecular Devices, Sunnyvale, CA, USA) and COMSTAT software from at least five
random images for each sample according to Heydorn et al. [53]. Four coupons of each surface were
analyzed. The experiment was repeated four times for a total of 16 coupons analyzed.
4.8. Statistical Analysis
Two-tailed ANOVA analysis, via software run in a MATLAB environment (Version 7.0,
The MathWorks Inc., Natick, MA, USA), was applied to statistically evaluate any significant differences
among the samples and concentrations. The ANOVA analysis was carried out after verifying data
independence (Pearson’s Chi-square test), normal distribution (D’Agostino-Pearson normality test),
and homogeneity of variance (Bartlett’s test). Tukey’s honest significant different test (HSD) was used
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for pairwise comparison to determine the significance of the data. Statistically significant results were
depicted by p < 0.05.
5. Conclusions
In this work, α-CT was successfully immobilized on an LDPE surface to provide a new
material able to inhibit biofilm colonization. The multiple-target nature of the protease activity
allows the new material to be used with a broad-spectrum activity against polymicrobial infections,
including drug-resistant strains. Indeed, the use of drugs that impact multiple targets simultaneously
is better at controlling complex disease systems, e.g., biofilms, and makes resistance development
rather unlikely [87–89].
LDPE-α-CT may provide a solution to potentiate the anti-biofilm activity of conventional
antimicrobials that are otherwise largely effective only against planktonic bacteria. Indeed, in many
industrial and clinical sector surface treatments that retard biofilm formation could represent a great
step forward against the challenge of biofilm formation [90]. Nowadays, the combination of antibiotics
with anti-biofilm mechanisms leading to synergism is considered the best solution for the treatment of
biofilm [91,92].
Both LDPE and α-CT are currently available at affordable prices, providing a positive
foundation for the production of LDPE-α-CT at the industrial level at affordable cost. Additionally,
the simple protocol for enzyme immobilization makes it suitable for application to other surfaces and
complementary enzymes, e.g., those attacking other components of the biofilm matrix.
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